-
Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page
49 Cents.....
- Thread starter anonymous
- Start date
-
- Tags
- None
No worries. GP and his southern sock puppet Tim will keep blowing sunshine up our skirts and tell us how great we are.
I’m not concerned though. TC never leaves his house so I don’t either-except to pick up the kids from school, hang by the pool, play golf, or occasionally make a call to sound like I know what’s going on.
And my manager is doing the same thing. The two day ride alongs are a box checking exercise. He gets here in time for our afternoon tee time, we have dinner and a couple beers, get our stories straight and make sure we’re tight until the next check in.
I never want to be on the top or the bottom. Middle of the middle is good. And that’s easy in this market with these products.
I’m not concerned though. TC never leaves his house so I don’t either-except to pick up the kids from school, hang by the pool, play golf, or occasionally make a call to sound like I know what’s going on.
And my manager is doing the same thing. The two day ride alongs are a box checking exercise. He gets here in time for our afternoon tee time, we have dinner and a couple beers, get our stories straight and make sure we’re tight until the next check in.
I never want to be on the top or the bottom. Middle of the middle is good. And that’s easy in this market with these products.
It’s all but over. Nowhere near enough revenue coming in from existing products and we’ve cut our expenses to the bone stock raise to fund the pipe dream of VEDS is a death rattle for Josh to fill his pockets
8 months ago, the stock was at .49c Today it's at $3.20!
Now factor in the 1 for 20 reverse split and the 8 month return on this pig is -67%.
Now factor in the 1 for 20 reverse split and the 8 month return on this pig is -67%.
Prepare for next week's earnings call. Lots of happy talk about big ADHD Q4 sales but it's all smoke and mirrors because of the Adderall shortage. But Josh knows it's not sustainable so the big news will be the Commercial reorg because of the overweighting of VPs and Chiefs at the top. GP and TB are getting their walking papers. Jason was put in to take over Gregs role and with the death of Healight, TB is no longer needed and it's past the contractual obligation that was part of the VEDS acquisition.
Will Jason keep TC in his position? Will jason take on the Aytuconnect pharmacy program leadership or TC get that?
Very quiet since the delay of the earnings release. Josh must not have cell service in Mexico
$2.04/share. Factor in the split and we’re barely worth a dime. This is after cutting expenses to the bone, no investment in future R&D, purging experience and hiring the cheapest sales force possible. All for nothing when the market leader goes generic before the fall season kicks in. It’s over
How do any of our leaders have jobs? TC, GP, JD have put this company in a death spiral. The hole has been dug. Generic Vyvanse puts us in the grave
"this additional capital enables us to advance the Company's growth and accelerate expense reduction initiatives and is expected to bridge the Company to profitability. Our strategic mandate is to focus on the most profitable aspects of our business. Going forward we will accentuate our Rx Segment and de-emphasize our Consumer Health Segment with the objective of either monetizing or discontinuing the Consumer Health Segment altogether."
- Consumer will be cut completely
- Accelerate expense reduction initiatives--more cuts across the board.
- Top heavy VPs and Chiefs will be whacked
- ADHD is becoming less profitable as market becomes more generic.
- Payers have already adjusted formularies in anticipation of generic Vyvanse
- Aytu scripts have been artificially propped up due to Adderall shortage
7.5 cents/share.
Less than 2 months until generic Vyvanse.
Nice work Josh.
Hire monkeys, you get a circus
Less than 2 months until generic Vyvanse.
Nice work Josh.
Hire monkeys, you get a circus
I used to work for these guys back in 2016 for the commercialization of Natesto. It was ALWAYS a circus.
I google the company every so often and I’m honestly just impressed the company still exists and employs people
I google the company every so often and I’m honestly just impressed the company still exists and employs people
7.5 cents/share.
Less than 2 months until generic Vyvanse.
Nice work Josh.
Hire monkeys, you get a circus
Just saw that GP exercised some options. Took the kids out for ice cream and tipped the server with both those dollars
two week until generic vyvanse. Schools start up in the south at the same time. GP and TC are already working on cutting territories and chopping any IC opportunities. They didn't tell all you sorority sisters that during the interview process did they?
Turn out the lights, the party's over
Turn out the lights, the party's over
What is the point of this company anymore? Our products are sh*t, we have nothing in development, no cash, and morons and scammers for leaders. Other than that, it's awesome
Aytu Bio... Fucked up by Josh Disbrow since 2015. Shocked he still has a job
- Honestly Josh and Jarrett aren't the issue. Trying to do their best. Sure Josh blows millions on himself from investor money. Np biggies. But TH and GP, absolute trash people. Look at their inside circle. It is just those two. They just keep replacing anyone else or people are smart enough to leave. No future with those two.